It looks like you're offline.
Open Library logo
additional options menu
In less than 1 day, we fight in court to restore access to 500,000+ books: Join us

MARC Record from marc_columbia

Record ID marc_columbia/Columbia-extract-20221130-011.mrc:24617662:2752
Source marc_columbia
Download Link /show-records/marc_columbia/Columbia-extract-20221130-011.mrc:24617662:2752?format=raw

LEADER: 02752cam a22004334a 4500
001 5028325
005 20221109210536.0
008 040315t20052005njua b 000 0 eng
010 $a 2004045778
015 $aGBA477096$2bnb
016 7 $a013023634$2Uk
020 $a0691120501 (cl. : alk. paper)
035 $a(OCoLC)ocm54822204
035 $a(NNC)5028325
035 $a5028325
040 $aDLC$cDLC$dUKM$dC#P$dOrLoB-B
042 $apcc
043 $an-us-ca
050 00 $aQH445.2$b.R336 2005
082 00 $a338.7/6606/09794$222
100 1 $aRabinow, Paul.$0http://id.loc.gov/authorities/names/n79082220
245 12 $aA machine to make a future :$bbiotech chronicles /$cPaul Rabinow and Talia Dan-Cohen.
260 $aPrinceton, N.J. :$bPrinceton University Press,$c[2005], ©2005.
300 $a199 pages :$billustrations ;$c24 cm
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
504 $aIncludes bibliographical references (p. [191]-193).
505 00 $tOverture : a machine to make a future --$gCh. 1.$tEnding and beginning --$gCh. 2.$tThe state of things at Celera Diagnostics, explained to investors and to anthropologists --$gCh. 3.$tThe machinery and its stewards --$gCh. 4.$tEthical and social consultancy --$gCh. 5.$tConfidence and trust --$gCh. 6.$tModels orient, technologies perform, samples speak (or vice versa) --$gCh. 7.$tSummer 2003 --$gApp.$tA corporate history.
520 1 $a"A Machine to Make a Future represents a remarkably original look at the present and possible future of biotechnology research in the wake of the mapping of the human genome. The central tenet of Celera Diagnostics - the California biotech company whose formative work during 2003 is the focus of the book - is that the emergent knowledge about the genome, with its profound implications for human health, can now be turned into a powerful diagnostic apparatus - one that will yield breakthrough diagnostic and therapeutic products (and potentially, profit)."--BOOK JACKET.
610 20 $aCelera Diagnostics.$0http://id.loc.gov/authorities/names/n2004007418
610 20 $aHuman Genome Project.$0http://id.loc.gov/authorities/names/n88044943
650 0 $aBiotechnology industries$zCalifornia.
650 0 $aBusiness anthropology.$0http://id.loc.gov/authorities/subjects/sh92001220
650 12 $aPhysical Chromosome Mapping.$0https://id.nlm.nih.gov/mesh/D020161
650 22 $aBiotechnology$xorganization & administration.$0https://id.nlm.nih.gov/mesh/D001709Q000458
650 22 $aGenetics, Medical.$0https://id.nlm.nih.gov/mesh/D005826
700 1 $aDan-Cohen, Talia,$d1982-$0http://id.loc.gov/authorities/names/n2004001586
852 00 $bleh$hQH445.2$i.R336 2005
852 00 $boff,hsl$hQH445.2$i.R336 2005